Trials / Completed
CompletedNCT00949884
Olmesartan Comparison to Losartan in Hypertensive Subjects
A Randomized, Double-blind, Active-comparator, 8-week Forced-titration Study of the Efficacy and Safety of Olmesartan Medoxomil Versus Losartan Potassium in Hypertensive Subjects
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 941 (actual)
- Sponsor
- Daiichi Sankyo · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the efficacy and safety of the FDA approved blood pressure medication olmesartan medoxomil compared to the FDA approved medication losartan potassium.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | olmesartan medoxomil | Oral tablets, once daily, at either 20mg or 40mg daily. |
| DRUG | Placebo | placebo oral tablets once daily for two weeks |
| DRUG | losartan potassium | losartan potassium oral tablet at either 50mg or 100 mg daily dose. |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2010-01-01
- Completion
- 2010-01-01
- First posted
- 2009-07-30
- Last updated
- 2011-03-09
- Results posted
- 2011-02-28
Locations
20 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00949884. Inclusion in this directory is not an endorsement.